Insider Transactions in Q1 2024 at Cara Therapeutics, Inc. (CARA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 29
2024
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
3,293
-3.49%
|
$0
$0.89 P/Share
|
|
Feb 29
2024
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,834
-3.13%
|
$0
$0.89 P/Share
|
|
Feb 29
2024
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,293
-5.54%
|
$0
$0.89 P/Share
|
|
Feb 08
2024
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
35,575
-16.03%
|
$0
$0.53 P/Share
|
|
Feb 01
2024
|
Joana Goncalves CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+16.73%
|
-
|
|
Feb 01
2024
|
Ryan D Maynard CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Feb 01
2024
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+11.68%
|
-
|
|
Feb 01
2024
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
4,981
-2.2%
|
$0
$0.55 P/Share
|
|
Feb 01
2024
|
Christopher Posner PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+21.6%
|
-
|
|
Feb 01
2024
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+7.47%
|
-
|